NCT04185610

A Mind-Body Intervention for Chemotherapy-Induced Peripheral Neuropathy

IIT2019-07-ASHER-QIGONG: A Mind-Body Intervention for Chemotherapy-Induced Peripheral Neuropathy

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 6 (actual)
• Sponsor: Arash Asher, MD · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This pilot study will include up to 25 patients with cancer experiencing chemotherapy-induced peripheral neuropathy. Patients enrolled in the study will participate in a 10-week QiGong for Chemotherapy-Induced Neuropathy program. Patients will be evaluated before and after their program participation. Within 2 weeks before the program start date, patients will be administered an objective neuropathy assessment by a physician or nurse, and will complete questionnaires assessing chemotherapy-induced peripheral neuropathy, perceived cognitive functioning, quality of life, and cancer-related symptoms. Patients will repeat these assessments at the end of the last QiGong class and will be asked to provide feedback on the QiGong program as a whole. Self-report questionnaires will also be repeated one week after the last class. Total duration of subject participation will be 11-13 weeks. Total duration of the study is expected to be approximately 9 months.

Conditions

• Chemotherapy-induced Peripheral Neuropathy
• Cancer

Interventions

Type	Name	Description
OTHER	Qi Gong	Guided Qi Gong class

Timeline

• Start date: 2019-12-04
• Primary completion: 2020-03-17
• Completion: 2020-03-17
• First posted: 2019-12-04
• Last updated: 2022-09-29

Locations

1 site across 1 country: United States